Patrick H. Warren

Patrick H. Warren is a seasoned global regulatory affairs executive with over 15 years of experience in guiding drug development, particularly in the fields of infectious diseases and vaccines. They currently serve as Senior Director of Global Regulatory Affairs for Eli Lilly and Company, focusing on cardiometabolic health. Previously, Patrick held significant roles in organizations such as Novavax, GSK, and Vericel Corporation, where they led regulatory strategies for critical vaccine programs and contributed to both early and late phase product development. Patrick is also a U.S. Army veteran and has advanced academic credentials from Harvard and Columbia University, reflecting their commitment to the field of biotechnology and global health.